Dabigatran Impurity 16, with the CAS number 211916-39-1, is a chemical compound that is recognized as an impurity associated with the anticoagulant drug dabigatran etexilate. This substance is typically characterized by its molecular structure, which includes specific functional groups that may influence its chemical behavior and stability. As an impurity, it is important to monitor its presence in pharmaceutical formulations to ensure product quality and safety. The compound may exhibit properties such as solubility in organic solvents, potential reactivity with other chemical species, and specific spectral characteristics that can be analyzed using techniques like NMR or mass spectrometry. Understanding the characteristics of such impurities is crucial for regulatory compliance and for maintaining the efficacy and safety of the primary drug. Additionally, the identification and quantification of impurities like Dabigatran Impurity 16 are essential in the context of drug development and quality control processes in the pharmaceutical industry.

Dabigatran Impurity 16

211916-39-1: Dabigatran Impurity 16, with the CAS number 211916-39-1, is a chemical compound that is recognized as an impurity associated with the anticoagulant drug dabigatran etexilate. This substance is typically characterized by its molecular structure, which includes specific functional groups that may influence its chemical behavior and stability. As an impurity, it is important to monitor its presence in pharmaceutical formulations to ensure product quality and safety. The compound may exhibit properties such as solubility in organic solvents, potential reactivity with other chemical species, and specific spectral characteristics that can be analyzed using techniques like NMR or mass spectrometry. Understanding the characteristics of such impurities is crucial for regulatory compliance and for maintaining the efficacy and safety of the primary drug. Additionally, the identification and quantification of impurities like Dabigatran Impurity 16 are essential in the context of drug development and quality control processes in the pharmaceutical industry.

CAS 211916-39-1

Dabigatran Impurity 16

Dabigatran Impurity 35

Ref: 4Z-D-5967

Dabigatran Impurity 10

Ref: ST-EA-CP-D5070